12
Participants
Start Date
December 12, 2019
Primary Completion Date
August 26, 2021
Study Completion Date
August 26, 2021
Lanadelumab
Lanadelumab solution, SC
Toyohashi Municipal Hospital, Toyohashi
Asahi General Hospital, Asahi-shi
Ogaki Municipal Hospital, Ogaki-shi
Hiroshima University Hospital, Hiroshima
Tomakomai City Hospital, Tomakomai-shi
Kobe University Hospital, Kobe
Tokai University Hospital, Isehara-shi
Yokohama City University Hospital, Yokohama
Kyoto University Hospital, Kyoto
Osaka University Hospital, Suita-shi
Saiyu Soka Hospital, Soka-shi
Shimane University Hospital, Izumo-shi
Lead Sponsor
Shire
INDUSTRY